Portfolio company
Range Biotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Range Bio
This company develops protein quantification tools for researchers and clinicians to improve diagnostic medicine and accelerate drug development.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
DC Biosciences
DC Biosciences provides proteomics services and research tools to pharmaceutical and biotechnology companies to support drug discovery and development processes.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
Quanterix
This company develops ultra-sensitive biomarker detection platforms and assay kits for pharmaceutical companies, academic institutions, and clinical laboratories.
Constellate Proteomics
This company develops single-molecule protein analysis platforms for biopharmaceutical drug developers to monitor antibody quality and rank cell lines during production.
